PittsburghV1, Canada, Analysis, bibRecord, 000307

Extracorporeal Treatment for Barbiturate Poisoning: Recommendations From the EXTRIP Workgroup

Identifieur interne : 000307 ( Canada/Analysis ); précédent : 000306; suivant : 000308

Extracorporeal Treatment for Barbiturate Poisoning: Recommendations From the EXTRIP Workgroup

Auteurs : Robert Mactier [Royaume-Uni] ; Martin Laliberte [Canada] ; Joelle Mardini [Canada] ; Marc Ghannoum [Canada] ; Valery Lavergne [Canada] ; Sophie Gosselin [Canada] ; Robert S. Hoffman [États-Unis] ; Thomas D. Nolin [États-Unis]

Source :

American journal of kidney diseases [ 0272-6386 ] ; 2014.

RBID : Pascal:14-0232877

Descripteurs français

Pascal (Inist)
- Traitement, Barbituriques, Intoxication, Recommandation, Hémodialyse, Néphrologie, Urologie.
Wicri :
- topic : Recommandation.

English descriptors

KwdEn :
- Barbiturates, Hemodialysis, Nephrology, Poisoning, Recommendation, Treatment, Urology.

Abstract

The EXTRIP (Extracorporeal Treatments in Poisoning) Workgroup conducted a systematic review of barbiturate poisoning using a standardized evidence-based process to provide recommendations on the use of extracorporeal treatment (ECTR) in patients with barbiturate poisoning. The authors reviewed all articles, extracted data, summarized key findings, and proposed structured voting statements following a predetermined format. A 2-round modified Delphi method was used to reach a consensus on voting statements, and the RAND/UCLA Appropriateness Method was used to quantify disagreement. 617 articles met the search inclusion criteria. Data for 538 patients were abstracted and evaluated. Only case reports, case series, and nonrandomized observational studies were identified, yielding a low quality of evidence for all recommendations. Using established criteria, the workgroup deemed that long-acting barbiturates are dialyzable and short-acting barbiturates are moderately dialyzable. Four key recommendations were made. (1) The use of ECTR should be restricted to cases of severe long-acting barbiturate poisoning. (2) The indications for ECTR in this setting are the presence of prolonged coma, respiratory depression necessitating mechanical ventilation, shock, persistent toxicity, or increasing or persistently elevated serum barbiturate concentrations despite treatment with multiple-dose activated charcoal. (3) Intermittent hemodialysis is the preferred mode of ECTR, and multiple-dose activated charcoal treatment should be continued during ECTR. (4) Cessation of ECTR is indicated when clinical improvement is apparent. This report provides detailed descriptions of the rationale for all recommendations. In summary, patients with long-acting barbiturate poisoning should be treated with ECTR provided at least one of the specific criteria in the first recommendation is present.

Affiliations:

Links toward previous steps (curation, corpus...)

to stream PascalFrancis, to step Corpus: 000600
to stream PascalFrancis, to step Curation: 004036
to stream PascalFrancis, to step Checkpoint: 000874
to stream Main, to step Merge: 005797
to stream Main, to step Curation: 005500
to stream Main, to step Exploration: 005500
to stream Canada, to step Extraction: 000307

Links to Exploration step

Pascal:14-0232877

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">Extracorporeal Treatment for Barbiturate Poisoning: Recommendations From the EXTRIP Workgroup</title>
<author><name sortKey="Mactier, Robert" sort="Mactier, Robert" uniqKey="Mactier R" first="Robert" last="Mactier">Robert Mactier</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Renal Services, NHS Greater Glasgow & Clyde</s1>
<s2>Glasgow, Scotland</s2>
<s3>GBR</s3>
<sZ>1 aut.</sZ>
</inist:fA14>
<country>Royaume-Uni</country>
<wicri:noRegion>Glasgow, Scotland</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Laliberte, Martin" sort="Laliberte, Martin" uniqKey="Laliberte M" first="Martin" last="Laliberte">Martin Laliberte</name>
<affiliation wicri:level="3"><inist:fA14 i1="02"><s1>Department of Emergency Medicine, McGill University Health Centre, McGill University</s1>
<s2>Montréal</s2>
<s3>CAN</s3>
<sZ>2 aut.</sZ>
</inist:fA14>
<country>Canada</country>
<placeName><settlement type="city">Montréal</settlement>
<region type="state">Québec</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Mardini, Joelle" sort="Mardini, Joelle" uniqKey="Mardini J" first="Joelle" last="Mardini">Joelle Mardini</name>
<affiliation wicri:level="1"><inist:fA14 i1="03"><s1>Department of Nephrology, Verdun Hospital, University of Montreal</s1>
<s2>Verdun</s2>
<s3>CAN</s3>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>Canada</country>
<wicri:noRegion>Verdun</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Ghannoum, Marc" sort="Ghannoum, Marc" uniqKey="Ghannoum M" first="Marc" last="Ghannoum">Marc Ghannoum</name>
<affiliation wicri:level="1"><inist:fA14 i1="03"><s1>Department of Nephrology, Verdun Hospital, University of Montreal</s1>
<s2>Verdun</s2>
<s3>CAN</s3>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>Canada</country>
<wicri:noRegion>Verdun</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Lavergne, Valery" sort="Lavergne, Valery" uniqKey="Lavergne V" first="Valery" last="Lavergne">Valery Lavergne</name>
<affiliation wicri:level="1"><inist:fA14 i1="04"><s1>Department of Medical Biology, Sacre-Coeur Hospital, University of Montreal</s1>
<s3>CAN</s3>
<sZ>5 aut.</sZ>
</inist:fA14>
<country>Canada</country>
<wicri:noRegion>Department of Medical Biology, Sacre-Coeur Hospital, University of Montreal</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Gosselin, Sophie" sort="Gosselin, Sophie" uniqKey="Gosselin S" first="Sophie" last="Gosselin">Sophie Gosselin</name>
<affiliation wicri:level="4"><inist:fA14 i1="05"><s1>Department of Emergency Medicine, Medical Toxicology Service, McGill University Health Centre, McGill University</s1>
<s2>Montréal, QC</s2>
<s3>CAN</s3>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>Canada</country>
<placeName><settlement type="city">Montréal</settlement>
<region type="state">Québec</region>
</placeName>
<orgName type="university">Université McGill</orgName>
</affiliation>
</author>
<author><name sortKey="Hoffman, Robert S" sort="Hoffman, Robert S" uniqKey="Hoffman R" first="Robert S." last="Hoffman">Robert S. Hoffman</name>
<affiliation wicri:level="1"><inist:fA14 i1="06"><s1>Division of Medical Toxicology, Department of Medicine, New York University School of Medicine</s1>
<s2>New York, NY</s2>
<s3>USA</s3>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<wicri:noRegion>New York, NY</wicri:noRegion>
</affiliation>
<affiliation wicri:level="1"><inist:fA14 i1="07"><s1>Division of Medical Toxicology, Department of Emergency Medicine, New York University School of Medicine</s1>
<s2>New York, NY</s2>
<s3>USA</s3>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<wicri:noRegion>New York, NY</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Nolin, Thomas D" sort="Nolin, Thomas D" uniqKey="Nolin T" first="Thomas D." last="Nolin">Thomas D. Nolin</name>
<affiliation wicri:level="1"><inist:fA14 i1="08"><s1>Department of Pharmacy and Therapeutics and University of Pittsburgh Schools of Pharmacy and Medicine</s1>
<s2>Pittsburgh, PA</s2>
<s3>USA</s3>
<sZ>8 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<wicri:noRegion>Department of Pharmacy and Therapeutics and University of Pittsburgh Schools of Pharmacy and Medicine</wicri:noRegion>
</affiliation>
<affiliation wicri:level="1"><inist:fA14 i1="09"><s1>Department of Medicine, Renal Electrolyte Division, University of Pittsburgh Schools of Pharmacy and Medicine</s1>
<s2>Pittsburgh, PA</s2>
<s3>USA</s3>
<sZ>8 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<wicri:noRegion>Pittsburgh, PA</wicri:noRegion>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">INIST</idno>
<idno type="inist">14-0232877</idno>
<date when="2014">2014</date>
<idno type="stanalyst">PASCAL 14-0232877 INIST</idno>
<idno type="RBID">Pascal:14-0232877</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">000600</idno>
<idno type="wicri:Area/PascalFrancis/Curation">004036</idno>
<idno type="wicri:Area/PascalFrancis/Checkpoint">000874</idno>
<idno type="wicri:explorRef" wicri:stream="PascalFrancis" wicri:step="Checkpoint">000874</idno>
<idno type="wicri:doubleKey">0272-6386:2014:Mactier R:extracorporeal:treatment:for</idno>
<idno type="wicri:Area/Main/Merge">005797</idno>
<idno type="wicri:Area/Main/Curation">005500</idno>
<idno type="wicri:Area/Main/Exploration">005500</idno>
<idno type="wicri:Area/Canada/Extraction">000307</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">Extracorporeal Treatment for Barbiturate Poisoning: Recommendations From the EXTRIP Workgroup</title>
<author><name sortKey="Mactier, Robert" sort="Mactier, Robert" uniqKey="Mactier R" first="Robert" last="Mactier">Robert Mactier</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Renal Services, NHS Greater Glasgow & Clyde</s1>
<s2>Glasgow, Scotland</s2>
<s3>GBR</s3>
<sZ>1 aut.</sZ>
</inist:fA14>
<country>Royaume-Uni</country>
<wicri:noRegion>Glasgow, Scotland</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Laliberte, Martin" sort="Laliberte, Martin" uniqKey="Laliberte M" first="Martin" last="Laliberte">Martin Laliberte</name>
<affiliation wicri:level="3"><inist:fA14 i1="02"><s1>Department of Emergency Medicine, McGill University Health Centre, McGill University</s1>
<s2>Montréal</s2>
<s3>CAN</s3>
<sZ>2 aut.</sZ>
</inist:fA14>
<country>Canada</country>
<placeName><settlement type="city">Montréal</settlement>
<region type="state">Québec</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Mardini, Joelle" sort="Mardini, Joelle" uniqKey="Mardini J" first="Joelle" last="Mardini">Joelle Mardini</name>
<affiliation wicri:level="1"><inist:fA14 i1="03"><s1>Department of Nephrology, Verdun Hospital, University of Montreal</s1>
<s2>Verdun</s2>
<s3>CAN</s3>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>Canada</country>
<wicri:noRegion>Verdun</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Ghannoum, Marc" sort="Ghannoum, Marc" uniqKey="Ghannoum M" first="Marc" last="Ghannoum">Marc Ghannoum</name>
<affiliation wicri:level="1"><inist:fA14 i1="03"><s1>Department of Nephrology, Verdun Hospital, University of Montreal</s1>
<s2>Verdun</s2>
<s3>CAN</s3>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>Canada</country>
<wicri:noRegion>Verdun</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Lavergne, Valery" sort="Lavergne, Valery" uniqKey="Lavergne V" first="Valery" last="Lavergne">Valery Lavergne</name>
<affiliation wicri:level="1"><inist:fA14 i1="04"><s1>Department of Medical Biology, Sacre-Coeur Hospital, University of Montreal</s1>
<s3>CAN</s3>
<sZ>5 aut.</sZ>
</inist:fA14>
<country>Canada</country>
<wicri:noRegion>Department of Medical Biology, Sacre-Coeur Hospital, University of Montreal</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Gosselin, Sophie" sort="Gosselin, Sophie" uniqKey="Gosselin S" first="Sophie" last="Gosselin">Sophie Gosselin</name>
<affiliation wicri:level="4"><inist:fA14 i1="05"><s1>Department of Emergency Medicine, Medical Toxicology Service, McGill University Health Centre, McGill University</s1>
<s2>Montréal, QC</s2>
<s3>CAN</s3>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>Canada</country>
<placeName><settlement type="city">Montréal</settlement>
<region type="state">Québec</region>
</placeName>
<orgName type="university">Université McGill</orgName>
</affiliation>
</author>
<author><name sortKey="Hoffman, Robert S" sort="Hoffman, Robert S" uniqKey="Hoffman R" first="Robert S." last="Hoffman">Robert S. Hoffman</name>
<affiliation wicri:level="1"><inist:fA14 i1="06"><s1>Division of Medical Toxicology, Department of Medicine, New York University School of Medicine</s1>
<s2>New York, NY</s2>
<s3>USA</s3>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<wicri:noRegion>New York, NY</wicri:noRegion>
</affiliation>
<affiliation wicri:level="1"><inist:fA14 i1="07"><s1>Division of Medical Toxicology, Department of Emergency Medicine, New York University School of Medicine</s1>
<s2>New York, NY</s2>
<s3>USA</s3>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<wicri:noRegion>New York, NY</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Nolin, Thomas D" sort="Nolin, Thomas D" uniqKey="Nolin T" first="Thomas D." last="Nolin">Thomas D. Nolin</name>
<affiliation wicri:level="1"><inist:fA14 i1="08"><s1>Department of Pharmacy and Therapeutics and University of Pittsburgh Schools of Pharmacy and Medicine</s1>
<s2>Pittsburgh, PA</s2>
<s3>USA</s3>
<sZ>8 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<wicri:noRegion>Department of Pharmacy and Therapeutics and University of Pittsburgh Schools of Pharmacy and Medicine</wicri:noRegion>
</affiliation>
<affiliation wicri:level="1"><inist:fA14 i1="09"><s1>Department of Medicine, Renal Electrolyte Division, University of Pittsburgh Schools of Pharmacy and Medicine</s1>
<s2>Pittsburgh, PA</s2>
<s3>USA</s3>
<sZ>8 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<wicri:noRegion>Pittsburgh, PA</wicri:noRegion>
</affiliation>
</author>
</analytic>
<series><title level="j" type="main">American journal of kidney diseases</title>
<title level="j" type="abbreviated">Am. j. kidney dis.</title>
<idno type="ISSN">0272-6386</idno>
<imprint><date when="2014">2014</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><title level="j" type="main">American journal of kidney diseases</title>
<title level="j" type="abbreviated">Am. j. kidney dis.</title>
<idno type="ISSN">0272-6386</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Barbiturates</term>
<term>Hemodialysis</term>
<term>Nephrology</term>
<term>Poisoning</term>
<term>Recommendation</term>
<term>Treatment</term>
<term>Urology</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Traitement</term>
<term>Barbituriques</term>
<term>Intoxication</term>
<term>Recommandation</term>
<term>Hémodialyse</term>
<term>Néphrologie</term>
<term>Urologie</term>
</keywords>
<keywords scheme="Wicri" type="topic" xml:lang="fr"><term>Recommandation</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">The EXTRIP (Extracorporeal Treatments in Poisoning) Workgroup conducted a systematic review of barbiturate poisoning using a standardized evidence-based process to provide recommendations on the use of extracorporeal treatment (ECTR) in patients with barbiturate poisoning. The authors reviewed all articles, extracted data, summarized key findings, and proposed structured voting statements following a predetermined format. A 2-round modified Delphi method was used to reach a consensus on voting statements, and the RAND/UCLA Appropriateness Method was used to quantify disagreement. 617 articles met the search inclusion criteria. Data for 538 patients were abstracted and evaluated. Only case reports, case series, and nonrandomized observational studies were identified, yielding a low quality of evidence for all recommendations. Using established criteria, the workgroup deemed that long-acting barbiturates are dialyzable and short-acting barbiturates are moderately dialyzable. Four key recommendations were made. (1) The use of ECTR should be restricted to cases of severe long-acting barbiturate poisoning. (2) The indications for ECTR in this setting are the presence of prolonged coma, respiratory depression necessitating mechanical ventilation, shock, persistent toxicity, or increasing or persistently elevated serum barbiturate concentrations despite treatment with multiple-dose activated charcoal. (3) Intermittent hemodialysis is the preferred mode of ECTR, and multiple-dose activated charcoal treatment should be continued during ECTR. (4) Cessation of ECTR is indicated when clinical improvement is apparent. This report provides detailed descriptions of the rationale for all recommendations. In summary, patients with long-acting barbiturate poisoning should be treated with ECTR provided at least one of the specific criteria in the first recommendation is present.</div>
</front>
</TEI>
<affiliations><list><country><li>Canada</li>
<li>Royaume-Uni</li>
<li>États-Unis</li>
</country>
<region><li>Québec</li>
</region>
<settlement><li>Montréal</li>
</settlement>
<orgName><li>Université McGill</li>
</orgName>
</list>
<tree><country name="Royaume-Uni"><noRegion><name sortKey="Mactier, Robert" sort="Mactier, Robert" uniqKey="Mactier R" first="Robert" last="Mactier">Robert Mactier</name>
</noRegion>
</country>
<country name="Canada"><region name="Québec"><name sortKey="Laliberte, Martin" sort="Laliberte, Martin" uniqKey="Laliberte M" first="Martin" last="Laliberte">Martin Laliberte</name>
</region>
<name sortKey="Ghannoum, Marc" sort="Ghannoum, Marc" uniqKey="Ghannoum M" first="Marc" last="Ghannoum">Marc Ghannoum</name>
<name sortKey="Gosselin, Sophie" sort="Gosselin, Sophie" uniqKey="Gosselin S" first="Sophie" last="Gosselin">Sophie Gosselin</name>
<name sortKey="Lavergne, Valery" sort="Lavergne, Valery" uniqKey="Lavergne V" first="Valery" last="Lavergne">Valery Lavergne</name>
<name sortKey="Mardini, Joelle" sort="Mardini, Joelle" uniqKey="Mardini J" first="Joelle" last="Mardini">Joelle Mardini</name>
</country>
<country name="États-Unis"><noRegion><name sortKey="Hoffman, Robert S" sort="Hoffman, Robert S" uniqKey="Hoffman R" first="Robert S." last="Hoffman">Robert S. Hoffman</name>
</noRegion>
<name sortKey="Hoffman, Robert S" sort="Hoffman, Robert S" uniqKey="Hoffman R" first="Robert S." last="Hoffman">Robert S. Hoffman</name>
<name sortKey="Nolin, Thomas D" sort="Nolin, Thomas D" uniqKey="Nolin T" first="Thomas D." last="Nolin">Thomas D. Nolin</name>
<name sortKey="Nolin, Thomas D" sort="Nolin, Thomas D" uniqKey="Nolin T" first="Thomas D." last="Nolin">Thomas D. Nolin</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Amérique/explor/PittsburghV1/Data/Canada/Analysis

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000307 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/Canada/Analysis/biblio.hfd -nk 000307 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Amérique
   |area=    PittsburghV1
   |flux=    Canada
   |étape=   Analysis
   |type=    RBID
   |clé=     Pascal:14-0232877
   |texte=   Extracorporeal Treatment for Barbiturate Poisoning: Recommendations From the EXTRIP Workgroup
}}

This area was generated with Dilib version V0.6.38.
Data generation: Fri Jun 18 17:37:45 2021. Site generation: Fri Jun 18 18:15:47 2021

	Serveur d'exploration sur Pittsburgh
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Serveur d'exploration sur Pittsburgh

Extracorporeal Treatment for Barbiturate Poisoning: Recommendations From the EXTRIP Workgroup

Extracorporeal Treatment for Barbiturate Poisoning: Recommendations From the EXTRIP Workgroup

Source :

Descripteurs français

English descriptors

Abstract

Links toward previous steps (curation, corpus...)

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri